Robert Forrester
About Robert Forrester
Robert Forrester is the Board Executive Chair and Chief Technology Officer at Anagenex, known for his role in advancing small molecule drug discovery.
Robert Forrester Board Executive Chair
Robert Forrester serves as the Board Executive Chair. His role involves providing strategic leadership and overseeing the governance of the organization. His position underscores his significant influence and responsibilities within the company's hierarchy.
Chief Technology Officer at Anagenex
In his capacity as Chief Technology Officer (CTO) at Anagenex, Robert Forrester manages the technological direction and strategy of the company. This includes leading research and development initiatives and integrating innovative technologies to advance Anagenex’s objectives within the biotechnology sector.
Robert Forrester Education and Expertise
Robert Forrester holds a Ph.D., a qualification that highlights his advanced knowledge and expertise in his field. This academic background equips him with the skills needed for high-level strategic and technical decision-making within the biotechnology and pharmaceutical sectors.
Multi-Target Collaboration for Small Molecule Therapeutics
Robert Forrester announced a multi-target collaboration to discover small molecule therapeutics for multiple indications. This initiative focuses on leveraging Anagenex’s scientific capabilities to identify and develop new treatment options, addressing various medical conditions with innovative small molecule drugs.
Series A Funding Round and Directed Evolution Platform
As part of the leadership team, Robert Forrester played a role when Anagenex closed a $30 million Series A funding round. Led by Catalio, this funding aims to advance small molecule drug discovery using Anagenex’s novel, directed evolution platform. This platform represents a significant technological advancement in drug development and discovery within the biotech industry.